Combination cancer immunotherapy and new immunomodulatory targets
Nature Reviews Drug Discovery2015Vol. 14(8), pp. 561–584
Citations Over TimeTop 1% of 2015 papers
Related Papers
- → Mechanisms of Resistance to PD-1 and PD-L1 Blockade(2018)396 cited
- → Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma(2020)52 cited
- → Inhibiting Immune Checkpoints for the Treatment of Bladder Cancer(2016)34 cited
- → A progressive T cell exhaustion program mapped across tissues in patients with lung cancer on immune checkpoint blockade(2023)4 cited
- → Distinct immunologic changes in vivo following combination versus individual PD-1 or CTLA-4 checkpoint blockade in human cancer(2014)